GlassScriptPhysician profile
Laura Bertrand
NPI 1104997238
$3,328.80
in general payments reported to CMS, 2019-2025
16 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $330 · 2021: $668 · 2022: $1,191 · 2023: $255 · 2024: $315 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,620.42 | 2021-2025 | Urolift |
| Abbvie INC. | $407.35 | 2023-2025 | Botox |
| Boston Scientific Corporation | $360.81 | 2019-2025 | Ams 700 |
| Neotract INC. | $260.42 | 2019-2020 | |
| Astellas Pharma US INC | $183.69 | 2019-2021 | |
| Axonics, INC. | $166.56 | 2021-2022 | |
| Medtronic, INC. | $125.42 | 2021-2025 | Altaviva |
| Endo Pharmaceuticals INC. | $34.81 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $32.37 | 2019 | |
| Medtronic USA, INC. | $26.91 | 2019-2020 | |
| Procept Biorobotics Corporation | $23.34 | 2019 | |
| Antares Pharma, INC. | $20.17 | 2021 | |
| Rochester Medical Corporation | $19.39 | 2021 | |
| Myovant Sciences INC. | $18.77 | 2021 | |
| Urovant Sciences INC | $15.86 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $12.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Bertrand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.